A U.S. judge rejected challenges by Bristol Myers Squibb and Johnson & Johnson to a law mandating negotiation of drug prices with Medicare or face penalties. The court dismissed claims of unconstitutionality, dealing a setback to the drugmakers.
Federal judge rules against two drugmakers challenging Medicare drug price negotiation program. https://t.co/9UJC7q3lgp
Healthcare and drugmaker groups sought to revive a challenge to US drug-pricing law. The groups sued the government last year, claiming the program, a signature initiative of Biden, violated the Constitution https://t.co/WEusP1Rlvi https://t.co/6ACgrFuPxr
Healthcare and drug industry groups urged a U.S. appeals court to revive their challenge to a law requiring manufacturers to negotiate the prices of some drugs with the U.S government's Medicare health insurance program or pay heavy penalties @brenpiers https://t.co/WEusP1QNFK https://t.co/jmPzfJSfXc
Healthcare and drug industry groups urged the 5th Circuit to revive their challenge to a law requiring manufacturers to negotiate the prices of some drugs with the US government's Medicare health insurance program or pay heavy penalties https://t.co/WEusP1Rlvi @brenpiers https://t.co/iJErIJ04d7
A federal judge threw out legal challenges to the Medicare negotiation program that had been brought by Bristol Myers Squibb and Johnson & Johnson, finding that their claims of unconstitutionality do not hold up. https://t.co/PoUveZyANu
Bristol Myers Squibb and J&J lost a court challenge to the Biden administration's Medicare drug price negotiation program. https://t.co/PqWFRMNYqU
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs. https://t.co/pqXp16dg8B
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations https://t.co/bKrNwnCYK3
A US judge rejected a challenge by Bristol Myers Squibb and J&J to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the US government's Medicare health insurance program or pay heavy penalties https://t.co/y8RNzsC1Jy https://t.co/Hn3XgZrLEd